RankingsPricing
  1. US-listed companies
  2. Elevance Health, Inc.
  3. Financials
  4. Repurchases of common stock

Elevance Health, Inc.ELV

Market cap
$81.1B
P/E ratio
SummaryFinancials
Period EndRepurchases of common stock (Million USD)YoY (%)
Dec 31, 20242,900+25.22%
Dec 31, 20222,316+21.89%
Dec 31, 20211,900-29.63%
Dec 31, 20202,700+58.73%
Dec 31, 20191,701+0.95%
Dec 31, 20181,685-15.65%
Dec 31, 20171,998+Infinity%
Dec 31, 20160-100.00%
Dec 31, 20151,516-49.45%
Dec 31, 20142,999+85.10%
Dec 31, 20131,620-46.70%
Dec 31, 20113,040-30.28%
Dec 31, 20104,360

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)